Bausch Health Companies Inc.
BHC
$5.71
-$0.18-3.06%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.50B | 2.23B | 2.53B | 2.48B | 2.38B |
| Total Other Revenue | 26.00M | 32.00M | 31.00M | 28.00M | 24.00M |
| Total Revenue | 2.53B | 2.26B | 2.56B | 2.51B | 2.40B |
| Cost of Revenue | 764.00M | 701.00M | 727.00M | 696.00M | 719.00M |
| Gross Profit | 1.77B | 1.56B | 1.83B | 1.81B | 1.68B |
| SG&A Expenses | 894.00M | 862.00M | 816.00M | 850.00M | 832.00M |
| Depreciation & Amortization | 256.00M | 256.00M | 259.00M | 274.00M | 270.00M |
| Other Operating Expenses | 1.00M | -- | -- | -- | 3.00M |
| Total Operating Expenses | 2.07B | 1.96B | 1.97B | 1.97B | 1.98B |
| Operating Income | 456.00M | 297.00M | 594.00M | 544.00M | 423.00M |
| Income Before Tax | 140.00M | -47.00M | 209.00M | -21.00M | 48.00M |
| Income Tax Expenses | 12.00M | 39.00M | 111.00M | 71.00M | 49.00M |
| Earnings from Continuing Operations | 128.00M | -86.00M | 98.00M | -92.00M | -1.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.00M | 28.00M | -5.00M | 7.00M | 11.00M |
| Net Income | 148.00M | -58.00M | 93.00M | -85.00M | 10.00M |
| EBIT | 456.00M | 297.00M | 594.00M | 544.00M | 423.00M |
| EBITDA | 763.00M | 602.00M | 901.00M | 866.00M | 741.00M |
| EPS Basic | 0.40 | -0.16 | 0.25 | -0.23 | 0.03 |
| Normalized Basic EPS | 0.01 | 0.03 | 0.40 | 0.37 | 0.15 |
| EPS Diluted | 0.40 | -0.16 | 0.25 | -0.23 | 0.03 |
| Normalized Diluted EPS | 0.01 | 0.03 | 0.40 | 0.37 | 0.15 |
| Average Basic Shares Outstanding | 370.90M | 369.60M | 372.00M | 368.40M | 367.90M |
| Average Diluted Shares Outstanding | 373.10M | 369.60M | 372.00M | 368.40M | 370.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |